Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 1255b-1 is a member of the miR-125 family, encoded by the MIR1255B1 gene and classified as a non-coding microRNA involved in regulatory functions at the post-transcriptional level[1][2]. Like other miR-125 family members, MIR1255B1 acts by incorporating into the RNA-induced silencing complex (RISC) to inhibit or destabilize target mRNAs through imperfect base pairing, thereby influencing processes such as cell differentiation, proliferation, apoptosis, and immune responses[1][3]. The miR-125 family, which includes MIR1255B1, has been implicated in both tumor suppressive and tumor promoting roles depending on disease context, particularly in various carcinomas and hematologic cancers such as B-cell acute lymphoblastic leukemia and acute myeloid leukemia[3]. While members of the miR-125 family are being explored as therapeutic targets and disease biomarkers, MIR1255B1 itself is primarily studied for its biological functions and disease associations rather than as a direct drug target[1][3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 1255b-1 (MIR1255B1).